MEDICALAI

AI is advancing. Mastery of decision-making must advance with it.

Choosing an artificial intelligence solution in healthcare involves far more than a technology purchase. It requires understanding what it delivers, the evidence supporting its claims, its limitations and the conditions under which it can be used.

Choosing an artificial intelligence solution in healthcare involves far more than a technology purchase. It requires understanding what it delivers, the evidence supporting its claims, its limitations and the conditions under which it can be used.

With MEDICALAI, AI informs your choice. You retain the decision.

This is the ambition of MEDICALAI, an independent decision intelligence platform for AI in healthcare, multi-jurisdictional by design, developed and led by KOCO WORLD PUBLISHING.

MEDICALAI Premium
MEDICALAI Premium

CLARIFY • UNDERSTAND • ACT

A COMPLEX ENVIRONMENT

Deciding in a fragmented environment

Calls for better mastery of AI reinforce this requirement. Trust must be grounded in verifiable elements and clearly identified responsibilities.

AI in healthcare is evolving rapidly, but useful information remains difficult to gather and contextualize.

Scattered information

Useful data is distributed across multiple sources, formats, and stakeholders.

Varying frameworks

Regulatory requirements differ across jurisdictions and evolve over time.

Evidence that is difficult to assess

Sources, statuses, and levels of evidence require rigorous contextualization.

Uneven maturity

Solutions are not at the same stage of development, validation, or deployment.

Demanding decisions

Before acting, decision-makers must cross-check multiple sources, assess alternatives, and understand limitations so their reasoning remains traceable.

THE MEDICALAI METHOD

From the question to a controlled decision

From the question to a controlled decision

The MEDICALAI analysis engine, currently under development, is designed to use AI as a tool for research, structuring, and analysis. It must explain the methodology followed, link conclusions to the sources and criteria that support them, and keep limitations, unknowns, and uncertainties visible.

The decision-maker retains control over the choice. The production and publication of MEDICALAI analyses remain under identifiable human responsibility.

01 — Need and question

Start from the professional need, define the decision to be informed, and clarify the question.

02 — Solutions

Identify relevant available or emerging solutions.

03 — Contexts and regulation

Place each option in its scientific, operational, and regulatory contexts, according to the applicable jurisdiction.

04 — Evidence

Link claims to sources, statuses, and levels of evidence, as well as to tests and user feedback when available.

05 — Independent analysis

Distinguish facts, vendor statements, and MEDICALAI analysis, while making limitations and uncertainties explicit.

06 — Comparison and alternatives

Compare options using explicit criteria, while keeping their limitations and missing data visible.

07 — Documented decision

Deliver an analysis that can be examined, explained, and revised, without replacing the decision-maker.

GLOBAL REACH

Multi-jurisdictional by design

The same healthcare AI solution must be understood and contextualized according to the jurisdiction, applicable regulatory framework, competent authority, status, use, evidence, and applicable conditions. MEDICALAI is designed for B2B and institutional professionals facing distinct frameworks, without artificial market standardization.

Jurisdiction · Applicable framework · Competent authority · Status · Usage · Evidence · Applicable conditions

VALUE PROPOSITION

Connecting needs to solutions and claims to evidence

MEDICALAI is being built to connect decision-makers’ needs with available and emerging solutions, test claims against evidence, and place every analysis in its scientific, operational, and regulatory context.

FROM FREEMIUM TO PREMIUM

Free access to stay informed, premium offers to support decisions

The freemium site is designed as a permanent free service, useful in its own right. It will provide access to selected editorial and informational content, MEDICALAI monitoring, and, progressively, discovery and search features adapted to the available corpus.

The premium offers currently under development will extend this foundation with advanced analyses and enriched decision comparisons. They are designed to help organizations prepare and document the compliance of AI solutions already in use by identifying potential gaps and matters to address, and also to prepare the selection and purchase of new products by comparing their claims, evidence, limitations, and conditions of use across jurisdictions.

Freemium informs and enables users to discover public content. Premium supports a documented professional decision without transferring the decision to AI or replacing the necessary medical, legal, or regulatory expertise.

THE ROLE OF ARTIFICIAL INTELLIGENCE

An explainable method serving human decision-making

Question → Research → Sources → Verification → Contextualization → Analysis → Comparison → Documented decision → New information and monitoring → Reassessment when necessary

In this approach, AI is a tool for research, structuring, and analysis. Conclusions must be open to examination, discussion, and revision based on the sources, criteria, and limitations that produced them.

Missing information and searches with no result remain explicitly identified. Failing to find evidence is not, by itself, sufficient to conclude that a solution is ineffective.

INDEPENDENCE AND GOVERNANCE

A traceable assessment under human responsibility

Facts, sources and analysis kept distinct

Provenance and traceability

Clear human accountability

Contradictions and unknowns retained

Editorial and commercial separation

Well-documented decision

This requirement also applies to MEDICALAI’s governance: independence of judgement, transparency of interests, source traceability and identifiable human responsibility.

GOVERNANCE

Governance White Paper

The White Paper formalizes the decision-making culture, the sustainable framework, and the common foundation guiding the governance of MEDICALAI. It is neither a procedural manual, an internal regulation, nor a strategic document.

Its ten principles connect evidence, independent judgment, accountability, execution, and trust to build documented decisions.

01 — Acknowledge what we do not know.

02 — Build decisions before making them.

03 — The project before people.

04 — Evidence precedes commitments.

05 — Execution reveals credibility.

06 — Continuous improvement prevails over certainty.

07 — Preserve independence of judgment.

08 — Pass on the method.

09 — The project’s long-term interest.

10 — Build trust.

DISCOVER THE WHITE PAPER

DEVELOPMENT

A platform built methodically

The MEDICALAI freemium site and analysis engine are under development. Their content, features, and interfaces will be rolled out progressively as they are validated.

The analysis approach is designed to continue beyond the initial choice. A new study, an incident, a change to the solution being assessed, or a regulatory development may justify reassessing a decision.

MEDICALAI’s ambition is to give organizations the means to adopt AI with discernment, justify their choices, and adapt them when the evidence changes.

Platform developed and operated by KOCO WORLD PUBLISHING.

CONTACT US

MEDICALAI

Project developed and operated by KOCO WORLD PUBLISHING.

© 2026 KOCO WORLD PUBLISHING. All rights reserved.

Intellectual property

The MEDICALAI figurative mark is the subject of a European Union trade mark application filed with the EUIPO under No. 019380397.

The MEDICALAI word mark is the subject of a registration application filed with the INPI under No. FR2612175.

The medicalai.ai domain name is held by KOCO WORLD PUBLISHING.